Panel recommends Serum Institute's name for phase 2, 3 human clinical trials of Oxford vaccine candidate

The recommendations of the committee at the Central Drugs Standard
Control Organisation have been sent to the Drugs Controller General of
India for approval.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms

Comments

Popular posts from this blog

CSIR-IGIB Research Project Posts Recruitment, Online Application Process

NISER PhD Program Admission 2020-21 (Winter Session)